Global S&T Development Trend Analysis Platform of Resources and Environment
Funding and manufacturing boost for UK vaccine programme | |
admin | |
2020-05-17 | |
发布年 | 2020 |
语种 | 英语 |
国家 | 英国 |
领域 | 气候变化 ; 资源环境 |
正文(英文) |
Press release
Funding and manufacturing boost for UK vaccine programmeUK’s top researchers rapidly working to find a coronavirus vaccine will benefit from £84 million of new government funding. ![]()
UK’s top researchers rapidly working to find a coronavirus vaccine will benefit from £84 million of new government funding, Business Secretary Alok Sharma has announced today (Sunday 17 May). The funding comes as Oxford University today agrees a global licensing agreement with AstraZeneca, the UK-based pharmaceutical company, for the commercialisation and manufacturing of their potential vaccine. This means that, if the Oxford vaccine is successful, AstraZeneca will work to make up to 30 million doses available by September for people in the UK, as part of an agreement to deliver 100 million doses in total. This will mean the UK will be the first country to get access to the vaccine, should it be successful. Business Secretary Alok Sharma said:
Pascal Soriot, Chief Executive Officer, AstraZeneca, said:
Professor Sir John Bell, Regius Professor of Medicine at Oxford University, said:
Professor Robin Shattock of Imperial College London said:
The UK is at the forefront of international efforts to research and develop a vaccine. The government has already pledged £250 million to the Coalition for Epidemic Preparedness Innovations (CEPI), the highest contribution of any country. This is part of the UK committing £388 million to the international drive to develop vaccines, tests and treatments. In June, the UK will also host the upcoming global pledging conference for Gavi, the Vaccine Alliance. Notes to editorsExpert Advisory Board membersThe expert advisory group advises, challenges and support the Vaccine Task Force in their goal to ensure that the UK population has access to clinically effective and safe vaccines as soon as possible. Chair: Patrick Vallance - GCSA, Government Office for Science
Published 17 May 2020
|
URL | 查看原文 |
来源平台 | GOV.UK - Department for Business, Energy & Industrial Strategy |
文献类型 | 新闻 |
条目标识符 | http://119.78.100.173/C666/handle/2XK7JSWQ/267493 |
专题 | 气候变化 资源环境科学 |
推荐引用方式 GB/T 7714 | admin. Funding and manufacturing boost for UK vaccine programme. 2020. |
条目包含的文件 | 条目无相关文件。 |
个性服务 |
推荐该条目 |
保存到收藏夹 |
查看访问统计 |
导出为Endnote文件 |
谷歌学术 |
谷歌学术中相似的文章 |
[admin]的文章 |
百度学术 |
百度学术中相似的文章 |
[admin]的文章 |
必应学术 |
必应学术中相似的文章 |
[admin]的文章 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论